Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.

Shrestha R, Nabavi N, Lin YY, Mo F, Anderson S, Volik S, Adomat HH, Lin D, Xue H, Dong X, Shukin R, Bell RH, McConeghy B, Haegert A, Brahmbhatt S, Li E, Oo HZ, Hurtado-Coll A, Fazli L, Zhou J, McConnell Y, McCart A, Lowy A, Morin GB, Chen T, Daugaard M, Sahinalp SC, Hach F, Le Bihan S, Gleave ME, Wang Y, Churg A, Collins CC.

Genome Med. 2019 Feb 18;11(1):8. doi: 10.1186/s13073-019-0620-3.

2.

Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.

Nabavi N, Wei J, Lin D, Collins CC, Gout PW, Wang Y.

Front Genet. 2018 Jul 4;9:232. doi: 10.3389/fgene.2018.00232. eCollection 2018. Review.

3.

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.

Choi SYC, Ettinger SL, Lin D, Xue H, Ci X, Nabavi N, Bell RH, Mo F, Gout PW, Fleshner NE, Gleave ME, Collins CC, Wang Y.

Cancer Med. 2018 Jun 14. doi: 10.1002/cam4.1587. [Epub ahead of print]

4.

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

Ramnarine VR, Alshalalfa M, Mo F, Nabavi N, Erho N, Takhar M, Shukin R, Brahmbhatt S, Gawronski A, Kobelev M, Nouri M, Lin D, Tsai H, Lotan TL, Karnes RJ, Rubin MA, Zoubeidi A, Gleave ME, Sahinalp C, Wyatt AW, Volik SV, Beltran H, Davicioni E, Wang Y, Collins CC.

Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy050.

5.

Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.

Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, Collins CC, Gleave ME, Gout PW, Wang Y.

Int J Cancer. 2018 Jul 15;143(2):419-429. doi: 10.1002/ijc.31310. Epub 2018 Mar 1.

6.

Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis.

Nabavi NS, Pezeshkpoor F, Valizadeh N, Ahmadi Ghezeldasht S, Rezaee SA.

Parasite Immunol. 2018 Jan;40(1). doi: 10.1111/pim.12507. Epub 2017 Dec 17.

7.

The Effect of 2 Different Exercise Programs on Pain Intensity and Muscle Dimensions in Patients With Chronic Low Back Pain: A Randomized Controlled Trial.

Nabavi N, Mohseni Bandpei MA, Mosallanezhad Z, Rahgozar M, Jaberzadeh S.

J Manipulative Physiol Ther. 2018 Feb;41(2):102-110. doi: 10.1016/j.jmpt.2017.03.011. Epub 2017 Jul 21.

PMID:
28739019
8.

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.

Nabavi N, Saidy NRN, Venalainen E, Haegert A, Parolia A, Xue H, Wang Y, Wu R, Dong X, Collins C, Crea F, Wang Y.

Sci Rep. 2017 Jun 22;7(1):4079. doi: 10.1038/s41598-017-03731-8.

9.

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.

Lin D, Ettinger SL, Qu S, Xue H, Nabavi N, Choi SYC, Bell RH, Mo F, Haegert AM, Gout PW, Fleshner N, Gleave ME, Pollak M, Collins CC, Wang Y.

Oncotarget. 2017 Apr 18;8(16):25928-25941. doi: 10.18632/oncotarget.15237.

10.

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment.

Nabavi N, Bennewith KL, Churg A, Wang Y, Collins CC, Mutti L.

Genes Cancer. 2016 Nov;7(11-12):340-354. doi: 10.18632/genesandcancer.124. Review.

11.

Adult Onset of Xanthelasmoid Mastocytosis: Report of a Rare Entity.

Nabavi NS, Nejad MH, Feli S, Bakhshoodeh B, Layegh P.

Indian J Dermatol. 2016 Jul-Aug;61(4):468. doi: 10.4103/0019-5154.185751.

12.

Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Kim SM, Wang Y, Nabavi N, Liu Y, Correia MA.

Drug Metab Rev. 2016 Aug;48(3):405-33. doi: 10.1080/03602532.2016.1195403. Epub 2016 Jun 20. Review.

13.

Symmetric signal and local oscillator polarization diverse coherent optical receiver.

Nabavi N, Hall TJ.

Opt Express. 2016 Feb 8;24(3):2391-405. doi: 10.1364/OE.24.002391.

PMID:
26906814
14.

Reliability of rehabilitative ultrasonography to measure transverse abdominis and multifidus muscle dimensions.

Nabavi N, Mosallanezhad Z, Haghighatkhah HR, Mohseni Bandpeid MA.

Iran J Radiol. 2014 Aug;11(3):e21008. doi: 10.5812/iranjradiol.21008. Epub 2014 Aug 20.

15.

Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders.

Sahebari M, Nabavi N, Salehi M.

Lupus. 2014 Oct;23(11):1164-77. doi: 10.1177/0961203314540966. Epub 2014 Jun 24. Review.

PMID:
24961748
16.
17.

SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.

Shin J, He M, Liu Y, Paredes S, Villanova L, Brown K, Qiu X, Nabavi N, Mohrin M, Wojnoonski K, Li P, Cheng HL, Murphy AJ, Valenzuela DM, Luo H, Kapahi P, Krauss R, Mostoslavsky R, Yancopoulos GD, Alt FW, Chua KF, Chen D.

Cell Rep. 2013 Nov 14;5(3):654-665. doi: 10.1016/j.celrep.2013.10.007. Epub 2013 Nov 7. Erratum in: Cell Rep. 2013 Dec 12;5(5):1479.

18.

EB1 levels are elevated in ascorbic Acid (AA)-stimulated osteoblasts and mediate cell-cell adhesion-induced osteoblast differentiation.

Pustylnik S, Fiorino C, Nabavi N, Zappitelli T, da Silva R, Aubin JE, Harrison RE.

J Biol Chem. 2013 Jul 26;288(30):22096-110. doi: 10.1074/jbc.M113.481515. Epub 2013 Jun 5.

19.

Rab GTPase mediated procollagen trafficking in ascorbic acid stimulated osteoblasts.

Nabavi N, Pustylnik S, Harrison RE.

PLoS One. 2012;7(9):e46265. doi: 10.1371/journal.pone.0046265. Epub 2012 Sep 26.

20.

Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.

Durand M, Komarova SV, Bhargava A, Trebec-Reynolds DP, Li K, Fiorino C, Maria O, Nabavi N, Manolson MF, Harrison RE, Dixon SJ, Sims SM, Mizianty MJ, Kurgan L, Haroun S, Boire G, de Fatima Lucena-Fernandes M, de Brum-Fernandes AJ.

Arthritis Rheum. 2013 Jan;65(1):148-58. doi: 10.1002/art.37722.

21.

Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion.

Nabavi N, Khandani A, Camirand A, Harrison RE.

Bone. 2011 Nov;49(5):965-74. doi: 10.1016/j.bone.2011.07.036. Epub 2011 Aug 2.

PMID:
21839189
22.

The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.

Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ.

Bone. 2011 Mar 1;48(3):588-96. doi: 10.1016/j.bone.2010.10.167. Epub 2010 Oct 17.

PMID:
20959150
23.

Optical waveguides formed by silver ion exchange in Schott SG11 glass for waveguide evanescent field fluorescence microscopy: evanescent images of HEK293 cells.

Hassanzadeh A, Nitsche M, Armstrong S, Nabavi N, Harrison R, Dixon SJ, Langbein U, Mittler S.

J Biomed Opt. 2010 May-Jun;15(3):036018. doi: 10.1117/1.3443796.

24.

Lysosome dispersion in osteoblasts accommodates enhanced collagen production during differentiation.

Nabavi N, Urukova Y, Cardelli M, Aubin JE, Harrison RE.

J Biol Chem. 2008 Jul 11;283(28):19678-90. doi: 10.1074/jbc.M802517200. Epub 2008 May 7.

25.

Musculoskeletal responses to high- and low-intensity resistance training in early postmenopausal women.

Bemben DA, Fetters NL, Bemben MG, Nabavi N, Koh ET.

Med Sci Sports Exerc. 2000 Nov;32(11):1949-57.

PMID:
11079527
26.

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix.

Cole DJ, Gattoni-Celli S, McClay EF, Metcalf JS, Brown JM, Nabavi N, Newton DA 3rd, Woolhiser CB, Wilson MC, Vournakis JN.

Clin Cancer Res. 1997 Jun;3(6):867-73.

27.

Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response.

Brown JA, Titus RG, Nabavi N, Glimcher LH.

J Infect Dis. 1996 Dec;174(6):1303-8.

PMID:
8940222
28.

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.

Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14002-7.

29.

Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.

Martin-Fontecha A, Cavallo F, Bellone M, Heltai S, Iezzi G, Tornaghi P, Nabavi N, Forni G, Dellabona P, Casorati G.

Eur J Immunol. 1996 Aug;26(8):1851-9.

PMID:
8765031
30.

Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.

Baskar S, Clements VK, Glimcher LH, Nabavi N, Ostrand-Rosenberg S.

J Immunol. 1996 May 15;156(10):3821-7.

PMID:
8621919
31.

Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation.

Cai YC, Cefai D, Schneider H, Raab M, Nabavi N, Rudd CE.

Immunity. 1995 Oct;3(4):417-26.

32.

IFN-gamma and b7 as costimulators of antitumor immune-responses.

Flores I, Sarkar S, Derosa C, Ozzello L, Nabavi N, Shen Y, Ron Y, Pestka S.

Int J Oncol. 1995 Sep;7(3):501-9.

PMID:
21552866
33.

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH.

Cell. 1995 Mar 10;80(5):707-18.

34.

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA.

J Exp Med. 1995 Mar 1;181(3):1145-55.

35.

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.

Baskar S, Glimcher L, Nabavi N, Jones RT, Ostrand-Rosenberg S.

J Exp Med. 1995 Feb 1;181(2):619-29.

36.

Immunoglobulin isotype regulation by antigen-presenting cells in vivo.

De Becker G, Sornasse T, Nabavi N, Bazin H, Tielemans F, Urbain J, Leo O, Moser M.

Eur J Immunol. 1994 Jul;24(7):1523-8.

PMID:
8026515
37.

Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.

Chen C, Gault A, Shen L, Nabavi N.

J Immunol. 1994 May 15;152(10):4929-36.

PMID:
7513726
38.
39.

Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes.

Chen C, Faherty DA, Gault A, Connaughton SE, Powers GD, Godfrey DI, Nabavi N.

J Immunol. 1994 Mar 1;152(5):2105-14.

PMID:
7510738
40.

Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody.

Powers GD, Faherty DA, Connaughton SE, Biondi DA, Godfrey DI, Gault A, Chen CY, Nabavi N.

Cell Immunol. 1994 Feb;153(2):298-311.

PMID:
7509723
41.

Expression and functional significance of an additional ligand for CTLA-4.

Lenschow DJ, Su GH, Zuckerman LA, Nabavi N, Jellis CL, Gray GS, Miller J, Bluestone JA.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11054-8.

42.

Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells.

Singer GG, Yokoyama H, Bloom RD, Jevnikar AM, Nabavi N, Kelley VR.

Kidney Int. 1993 Nov;44(5):1030-5.

43.

Tumor cells expressing major histocompatibility complex class II and B7 activation molecules stimulate potent tumor-specific immunity.

Baskar S, Nabavi N, Glimcher LH, Ostrand-Rosenberg S.

J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):209-15.

PMID:
8297902
44.

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH.

Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5687-90.

45.

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.

Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH.

Nature. 1992 Nov 19;360(6401):266-8.

PMID:
1279442
46.

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, et al.

Proc Natl Acad Sci U S A. 1991 May 15;88(10):4143-7.

47.

Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Hidore MR, Nabavi N, Sonleitner F, Murphy JW.

Infect Immun. 1991 May;59(5):1747-54.

48.
49.

Casein expression in cytotoxic T lymphocytes.

Grusby MJ, Mitchell SC, Nabavi N, Glimcher LH.

Proc Natl Acad Sci U S A. 1990 Sep;87(17):6897-901.

50.

Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans.

Hidore MR, Nabavi N, Reynolds CW, Henkart PA, Murphy JW.

J Leukoc Biol. 1990 Jul;48(1):15-26.

PMID:
2193078

Supplemental Content

Loading ...
Support Center